Literature DB >> 12210410

Sequence analysis of pre-S/surface and pre-core/core promoter genes of hepatitis B virus in chronic hepatitis C patients with occult HBV infection.

Jia-Horng Kao1, Pei-Jer Chen, Ming-Yang Lai, Ding-Shinn Chen.   

Abstract

Although occult hepatitis B virus (HBV) infection in individuals without detectable hepatitis B surface antigen (HBsAg) may occur and has been reported to be common in patients with chronic hepatitis C, the related molecular mechanisms remain unknown. With the polymerase chain reaction, serum HBV DNA was sought in 100 HBsAg-negative patients with chronic hepatitis C virus (HCV)-infection. In those with occult HBV infection, possible genomic variability of HBV was evaluated by amplification and direct sequencing of pre-S, surface, and pre-core/core promoter genes. In total, 10 of the 100 patients (10%) had detectable serum HBV DNA, documenting an occult HBV infection. A deletion mutant in the pre-S gene was found in one patient and mutations of the a determinant of HBsAg were observed in 2. In addition, a novel core promoter mutant (a dinucleotide substitution: T-to-C at nucleotide 1,802 and T-to-G at nucleotide 1,803, T1802C/T1803G) was found frequently in patients with occult HBV infection as compared to sex- and age-matched HBsAg-positive patients (80 vs. 10%, P < 0.001). In conclusion, the data suggest occult HBV infection is not uncommon in chronic hepatitis C patients in Taiwan, and a novel core promoter mutant may be associated with the absence of circulating HBsAg in these patients. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12210410     DOI: 10.1002/jmv.10188

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  9 in total

1.  Serologic and molecular characteristics of hepatitis B virus among school children in East Java, Indonesia.

Authors:  Takako Utsumi; Yoshihiko Yano; Maria Inge Lusida; Mochamad Amin; Hak Hotta; Yoshitake Hayashi
Journal:  Am J Trop Med Hyg       Date:  2010-07       Impact factor: 2.345

2.  Genomic variability associated with the presence of occult hepatitis B virus in HIV co-infected individuals.

Authors:  C M Martin; J A Welge; N J Shire; S D Rouster; M T Shata; K E Sherman; J T Blackard
Journal:  J Viral Hepat       Date:  2009-11-02       Impact factor: 3.728

3.  Mutations associated with occult hepatitis B virus infection result in decreased surface antigen expression in vitro.

Authors:  C M Martin; J A Welge; S D Rouster; M T Shata; K E Sherman; J T Blackard
Journal:  J Viral Hepat       Date:  2012-06-04       Impact factor: 3.728

4.  A weak association between occult HBV infection and non-B non-C hepatocellular carcinoma in Japan.

Authors:  Atsunori Kusakabe; Yasuhito Tanaka; Etsuro Orito; Fuminaka Sugauchi; Fuat Kurbanov; Tomoyuki Sakamoto; Noboru Shinkai; Noboru Hirashima; Izumi Hasegawa; Tomoyoshi Ohno; Ryuzo Ueda; Masashi Mizokami
Journal:  J Gastroenterol       Date:  2007-04-26       Impact factor: 7.527

5.  Mutations associated with occult hepatitis B in HIV-positive South Africans.

Authors:  Eleanor A Powell; Maemu P Gededzha; Michael Rentz; Nare J Rakgole; Selokela G Selabe; Tebogo A Seleise; M Jeffrey Mphahlele; Jason T Blackard
Journal:  J Med Virol       Date:  2014-08-27       Impact factor: 2.327

6.  Prevalence and molecular characterization of hepatitis D virus in Saudi Arabia: A single-center study.

Authors:  Ghazi A Jamjoom; Mai M El-Daly; Esam I Azhar; Hind I Fallatah; Hisham O Akbar; Mohammed Babatin; Abdullah S Alghamdi; Mohammed I Dgdgi; Mohamed A Hamid; Yousef A Qari; Sherif A El-Kafrawy
Journal:  Saudi J Gastroenterol       Date:  2017 May-Jun       Impact factor: 2.485

7.  Hepatitis B virus genotypes and evolutionary profiles from blood donors from the northwest region of China.

Authors:  Xing-Bin Hu; Qiao-Hong Yue; Xian-Qing Zhang; Xue-Qing Xu; Yin Wen; Yao-Zhen Chen; Xiao-Dong Cheng; Liu Yang; Shi-Jie Mu
Journal:  Virol J       Date:  2009-11-17       Impact factor: 4.099

8.  Characterization of Novel Hepatitis B Virus PreS/S-Gene Mutations in a Patient with Occult Hepatitis B Virus Infection.

Authors:  Jianhong Chen; Yan Liu; Jun Zhao; Zhihui Xu; Rongjuan Chen; Lanlan Si; Shanshan Lu; Xiaodong Li; Shuai Wang; Kai Zhang; Jin Li; Juqiang Han; Dongping Xu
Journal:  PLoS One       Date:  2016-05-16       Impact factor: 3.240

9.  Risk of Reverse Seroconversion of Hepatitis B Virus Surface Antigen in Rituximab-Treated Non-Hodgkin Lymphoma Patients: A Large Cohort Retrospective Study.

Authors:  Liang-Tsai Hsiao; Tzeon-Jye Chiou; Jyh-Pyng Gau; Ching-Fen Yang; Yuan-Bin Yu; Chun-Yu Liu; Jin-Hwang Liu; Po-Min Chen; Cheng-Hwai Tzeng; Yu-Jiun Chan; Muh-Hwa Yang; Yi-Hsiang Huang
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.